Brinker Capital’s Medpace MEDP Stock Holding History

Brinker Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,263	Closed	-$255K	–	946
2018 Q3	$255K	Buy	+4,263	New	+$233K	0.01%	896

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Brinker Capital's MEDP Position: Q4 2018 in Review

Brinker Capital sold out of Medpace (MEDP) in Q4 2018, closing a stake of 4,263 shares — an estimated $255K sold.

Brinker Capital first reported a position in MEDP in Q3 2018 and held it in 1 quarter. The position peaked at $255K in Q3 2018. 216 funds tracked by Wall St. Rank hold MEDP as of Q4 2018.

Brinker Capital reported no remaining Medpace position as of Q4 2018 after selling out during the quarter.
Brinker Capital sold 4,263 Medpace shares in Q4 2018, an estimated $255K.
Brinker Capital first reported a position in Medpace in Q3 2018 and held it in 1 quarter.
Brinker Capital's Medpace position peaked at $255K in Q3 2018.
216 funds tracked by Wall St. Rank held Medpace as of Q4 2018.

Based on Brinker Capital's 13F filing for Q4 2018, filed 14 Feb 2019.